← Leaderboards
Langston Tyler Holly
Washington University
$4,321,887
Attributed
$9,066,374
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,066,374 · 3
By mechanism
K12$5,026,009 · 1
R01$3,619,175 · 1
R21$421,190 · 1
Top collaborators
- Benjamin M. Ellingson5 shared
- Sepideh Amin-Hanjani4 shared
- Emad N Eskandar4 shared
- Gregory J Zipfel4 shared
Most similar at Washington University
Same institution · by research overlap
- David F Wozniak$3,135,842
- Sheng-Kwei Song$14,973,079
- Julie C. Leonard$3,684,521
- Mayssa H. Mokalled$4,046,941
- Katherine Nelson Weilbaecher$8,913,824
Others in their field
Top investigators on “Pathogenesis”
- Jeffrey P Krischer · University Of South Florida$473,867,135
- Constance Ann Benson · University Of California, San Diego$309,631,408
- Daniel R Kuritzkes · Brigham And Women'S Hospital$212,627,101
- Richard K. Wilson · Washington University$203,917,615
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$198,007,440
- Carol Nesel · Westat$147,274,423
Research focus
PathogenesisResponseCervicalNeurosurgeryOperative Surgical ProceduresDisease ProgressionNeurological RecoveryMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMeasurementMonitorNeuraxisNormal AgingNervous System PhysiologyAffectCell PhysiologyAge-YearsBiochemistryAdultFunctional DisorderBrainChronicIntervertebral Disk DegenerationRunning
Grant awards (16)
Neurosurgeon Research Career Development Program (NRCDP)$1,663,132
K12 · FY2025 · NS
Neurosurgeon Research Career Development Program (NRCDP)$1,663,132
K12 · FY2024 · NS
Neurosurgeon Research Career Development Program (NRCDP)$1,478,075
K12 · FY2023 · NS
Neurosurgeon Research Career Development Program (NRCDP)$221,670
K12 · FY2023 · NS
Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury$388,139
R01 · FY2022 · NS · contact PI
Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury$388,139
R01 · FY2021 · NS · contact PI
Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury$388,139
R01 · FY2020 · NS · contact PI
Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury$388,139
R01 · FY2019 · NS · contact PI
Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury$397,404
R01 · FY2018 · NS · contact PI
MRS and DTI as biomarkers of spinal cord viability in chronic spinal cord injury$336,875
R01 · FY2016 · NS · contact PI
MRS and DTI as biomarkers of spinal cord viability in chronic spinal cord injury$336,875
R01 · FY2015 · NS · contact PI
MRS and DTI as biomarkers of spinal cord viability in chronic spinal cord injury$333,505
R01 · FY2014 · NS · contact PI
MRS and DTI as biomarkers of spinal cord viability in chronic spinal cord injury$325,085
R01 · FY2013 · NS · contact PI
MRS and DTI as biomarkers of spinal cord viability in chronic spinal cord injury$336,875
R01 · FY2012 · NS · contact PI
MR Spectroscopy to Explore Spinal Cord Viability in Chronic Spinal Cord Injury$228,690
R21 · FY2010 · NS · contact PI
MR Spectroscopy to Explore Spinal Cord Viability in Chronic Spinal Cord Injury$192,500
R21 · FY2009 · NS · contact PI